Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
330.64
+0.13 (+0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
June 12, 2024
Enthusiasm is growing for a looming approval in COPD treatment.
Via
Investor's Business Daily
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
June 10, 2024
The company is focusing on obesity treatment after its glaucoma drug failed.
Via
Investor's Business Daily
Is Geron Stock a Buy Following Its First New Drug Approval?
June 08, 2024
Find out if the high-flying biotech stock can keep on climbing higher.
Via
The Motley Fool
Market Whales and Their Recent Bets on AMGN Options
June 06, 2024
Via
Benzinga
Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
June 05, 2024
Amgen announced Phase 3 trial results for Uplizna for IgG4-related disease, achieving an 87% reduction in flare risk. All key secondary endpoints were met with no new safety signals.
Via
Benzinga
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
June 03, 2024
There's probably a big enough pie here for everyone to get a slice.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years
May 31, 2024
Via
Benzinga
Where Will Amgen Be in 3 Years?
May 29, 2024
The Amgen of 2027 could be much be larger than some investors expect.
Via
The Motley Fool
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $5,700 Today
May 21, 2024
Via
Benzinga
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
May 29, 2024
The FDA has approved Amgen's Bkemv as the first interchangeable biosimilar to AstraZeneca's Soliris for treating rare diseases.
Via
Benzinga
Exposures
Product Safety
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF
May 28, 2024
As weight loss drugs are gaining popularity Roundhill GLP 1 And Weight Loss ETF (OZEM) has launched as anew way to invest in them.
Via
InvestorPlace
Topics
ETFs
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
May 26, 2024
The gold rush for obesity medications just got a bit more intense.
Via
The Motley Fool
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
May 24, 2024
Verastem Oncology reports promising initial results from the RAMP 205 trial with an 83% ORR for avutometinib and defactinib in metastatic pancreatic cancer. FDA submission for recurrent KRAS mutant...
Via
Benzinga
Exposures
Product Safety
Stocks to Buy: 7 Undeniable Dow Darlings to Pile Into Now
May 24, 2024
Most Dow stocks are strong investments but these 7 stand out at the moment as the macroenvironment trends positive again.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Amgen Unusual Options Activity
May 17, 2024
Via
Benzinga
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
May 21, 2024
Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day."
Via
Benzinga
Topics
ETFs
7 Reliable Blue-Chip Stocks That Cannot Miss
May 21, 2024
These reliable blue-chip stocks to own are the closest thing to slam dunk investments that exist. Discover why you should buy them now.
Via
InvestorPlace
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
May 20, 2024
Amgen and AstraZeneca reveal Phase 2a results for Tezspire in severe COPD, showing a 17% reduction in exacerbations, with notable improvements in lung function and quality of life for patients with...
Via
Benzinga
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
May 20, 2024
Thanks to the underlying pertinence, these established biotech stocks to buy offer confidence to investors facing tricky market conditions.
Via
InvestorPlace
Dow Jones Industrial Average Closes Above 40,000 In Quiet Friday Climb
May 19, 2024
The Dow Jones Industrial Average closed above the 40,000.00 major handle for the first time ever after markets wound down a hectic trading week that saw rate cut hopes return to the forefront after US...
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?
May 19, 2024
Eli Lilly's biggest growth drivers today are its weight loss drugs.
Via
The Motley Fool
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?
May 17, 2024
Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.
Via
InvestorPlace
FDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer Patients
May 17, 2024
FDA approves Amgen's Imdelltra for treating ES-SCLC, based on response rate and DoR in clinical studies. Approval may depend on further trials.
Via
Benzinga
Exposures
Product Safety
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
May 17, 2024
Could Amgen be the next stock to soar due to a GLP-1 drug?
Via
The Motley Fool
S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally
May 15, 2024
The S&P 500, Nasdaq 100 and Dow Jones Industrial Average indices all shattered fresh all-time highs Wednesday, driven by a benign inflation report that boosted risk sentiment among bullish investors.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
The 3 Best Dow Stocks to Buy in May 2024
May 13, 2024
The Dow Jones Industrial Average has been on a hot streak this month. Here are the three best Dow stocks to buy.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors
May 12, 2024
The biotech's pipeline extends far beyond this exciting weight-loss product.
Via
The Motley Fool
5 Stocks Driving Dow's Market-Beating Performance
May 11, 2024
While 27 of the 30 members of the Dow Jones Index have performed well over the last seven days, we have highlighted five of them that have been leading the way higher.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
May 09, 2024
The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.